By Pritam Biswas and Prakhar Srivastava (Reuters) -Sports technology firm Enhanced said on Wednesday it will go public in the U.S. ​through a merger with special purpose acquisition company A Paradise Acquisition Corp, ‌in a deal valued at $1.2 billion. Blank-check firms are staging a comeback on Wall Street this ‌year after a prolonged downturn, with seasoned sponsors reviving SPACs as an alternative route to public listings. Financial services firm SWB, data center operator Blockfusion and Teamshares ...

Group 1: Clean Energy Sector - Clean Energy Technologies, Inc. (CETY) has seen a price increase of 146.73%, reaching $2.64, driven by its innovative approach in energy efficiency and renewable solutions [1][7] - CETY's acquisition of a $10 million Battery Energy Storage System (BESS) project in New York State marks a significant milestone and the largest storage initiative undertaken by the company [1][7] - The trading volume for CETY reached 260,282,741, indicating strong investor interest [1] Group 2: Mergers and Acquisitions - Flag Ship Acquisition Corporation (FSHPR) experienced a price increase of 58.20% to $0.19, reflecting growing investor appetite for companies with strategic acquisition plans [2][7] - DT Cloud Star Acquisition Corporation (DTSQR) saw its price rise by 44.53% to $0.21, driven by interest in companies seeking to expand through strategic business combinations in the technology sector [4][7] - Calisa Acquisition Corp Right (ALISR) experienced a 38% increase in price to $0.24, indicating interest in alternative investment vehicles and potential returns from successful business combinations [5][7] Group 3: Biotechnology Sector - Revolution Medicines, Inc. Warrant (RVMDW) saw a price increase of 57.28% to $1.005, focusing on developing targeted therapies for RAS-addicted cancers [3][7] - The biotechnology sector continues to attract attention for its potential to offer groundbreaking treatments, as evidenced by RVMDW's trading volume of 26,884 [3]

Core Points - StoneBridge Acquisition II Corporation announced that starting November 21, 2025, holders of units from its initial public offering can separately trade Class A ordinary shares and rights included in those units [1][2] - The Class A ordinary shares and rights will trade on the Nasdaq Capital Market under the symbols "APAC" and "APACR," while units that are not separated will continue to trade under the symbol "APACU" [2] - Each unit consists of one Class A ordinary share and one right, with each right entitling the holder to receive one-tenth (1/10) of one Class A ordinary share upon the completion of the Company's initial business combination [3] Company Overview - StoneBridge Acquisition II Corporation is a blank check company, also known as a special purpose acquisition company (SPAC), formed to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses [5]

Group 1 - The Company, Calisa Acquisition Corp, will allow holders of its units to separately trade ordinary shares and rights starting on or about November 19, 2025 [1] - The ordinary shares will trade under the symbol "ALIS" and the rights under "ALISR" on the Nasdaq Global Market [1] - Units that are not separated will continue to trade under the symbol "ALISU" [1] Group 2 - The Company is a Cayman exempt company formed as a blank check company aimed at merging or acquiring businesses, particularly focusing on opportunities in Asia [2]

Group 1: BETA Technologies - BETA Technologies went public on November 4, raising $1.015 billion by issuing 29.85 million shares at an initial price of $34 per share [3] - On its first trading day, BETA's stock opened at $34, reached a high of $38.33, and closed at $36, marking a 5.88% increase and a total market capitalization of $7.88 billion [1] - The company specializes in the development of electric vertical takeoff and landing (eVTOL) aircraft, including related electric propulsion systems and charging solutions [4] Group 2: Functional Brands - Functional Brands listed on NASDAQ through a direct listing, offering over 150 health supplement products, including probiotics, vitamins, and amino acids [4] - For the first half of 2025, Functional Brands reported revenue of $342,000, a slight decrease from $349,000 in the same period the previous year, with a net loss of $35,000 compared to a profit of $700 [4] Group 3: SPACs - Cantor Equity Partners V (CEPV) and Westin Acquisition (WSTNU) are both special purpose acquisition companies (SPACs) that entered NASDAQ, raising $220 million and $50 million, respectively [4] - CEPV, based in New York, aims to target acquisitions in financial services, digital assets, healthcare, real estate services, technology, and software sectors [5] - Westin Acquisition, headquartered in Singapore, plans to focus on companies in the Asia-Pacific region with significant growth potential [5]

Core Points - Miluna Acquisition Corp has priced its initial public offering (IPO) at $10.00 per unit, with a total of 6,000,000 units being offered [1] - The units will be listed on the Nasdaq Global Market under the ticker symbol "MMTXU" starting October 23, 2025 [1] - Each unit consists of one ordinary share and one redeemable warrant, with separate trading expected for the shares and warrants under the symbols "MMTX" and "MMTXW" respectively [1] Offering Details - D. Boral Capital LLC and ARC Group Securities LLC are the joint book-running managers for the offering [2] - The underwriters have a 45-day option to purchase an additional 900,000 units to cover over-allotments [2] - The offering is anticipated to close on October 24, 2025, subject to customary closing conditions [2] Company Background - Miluna Acquisition Corp is a blank check company aimed at executing mergers, share exchanges, asset acquisitions, and similar business combinations [5] - The company is open to pursuing targets in any industry or geographic region, except for those based in or primarily operating in the People's Republic of China [5] Regulatory Information - A registration statement for the securities was declared effective by the Securities and Exchange Commission on September 30, 2025 [3] - The offering is being conducted solely through a prospectus, which can be obtained from the underwriters [3]

Core Insights - 1789 Capital, launched in 2022 by Omeed Malik and Chris Buskirk, aims to support American exceptionalism and is associated with Donald Trump's political endeavors [1][7] - SPACs, or special purpose acquisition companies, are utilized to take private companies public while bypassing traditional regulatory scrutiny [2][6] - Colombier Acquisition Corp. III, backed by Omeed Malik, filed for an IPO to raise $260 million by offering 26 million shares at $10 each [7] Company Developments - Donald Trump Jr. is a director at Colombier Acquisition Corp. III and has been a partner at 1789 Capital since November 2024 [7] - GrabAGun, a firearms retailer supported by Donald Trump Jr., went public through a merger with Colombier Acquisition Corp. II, which is also backed by Malik [4][7] - Roth Capital is the underwriter for the offering of Colombier Acquisition Corp. III [4][7] Industry Context - The recent activities of the Trump family include ventures into cryptocurrency and meme coins, indicating a broader strategy in emerging financial markets [2][7] - The trend of using SPACs reflects a growing preference among companies to access public markets with less regulatory burden [2][6]

Core Insights - Several companies have experienced significant stock price increases, attracting investor attention and market analysis [1] Company Summaries - **Xenetic Biosciences, Inc.**: Achieved a 142.31% increase in stock price, closing at $10.39, with a trading volume of 45,373,947. The company focuses on immuno-oncology technologies and has expanded its partnership with The Scripps Research Institute to advance CAR T-cell therapies [2] - **bioAffinity Technologies, Inc.**: Stock price rose by 108.60% to $0.48, with a volume of 29,850. The company specializes in non-invasive cancer diagnosis and treatment, showcasing the clinical value of its CyPath® Lung in detecting early-stage lung cancer [3] - **GigCapital7 Corp.**: Recorded an 89.43% increase in stock price, ending at $1.58. This SPAC is gaining interest due to its business combination with BigBear.ai, which has a pro forma enterprise value of $1.378 billion and aims to capitalize on AI/ML market opportunities [4] - **AlphaTON Capital Corp.**: Experienced an 85.48% rise in stock price to $10.35. The company is transitioning to a digital asset treasury model focused on Toncoin (TON) and is exploring the tokenization of single-indication economics for mesothelioma [5] - **Acurx Pharmaceuticals, Inc.**: Stock price increased by 74.36% to $7.48. The company is developing antibiotics for bacterial infections and received a positive opinion from the European Medicines Agency for its Pediatric Investigation Plan, positioning it for international Phase 3 clinical trials [6] Market Dynamics - The performances of these companies illustrate the dynamic nature of the stock market and the potential for significant returns, prompting investors and analysts to monitor future developments closely [7][8]

Core Viewpoint - The SPAC market, which gained popularity during the Covid-19 pandemic, has seen mixed results, leading to skepticism among investors regarding future SPAC deals [1][2]. Group 1: SPAC Market Overview - The SPAC craze of 2020 and 2021 attracted many retail investors due to favorable market conditions, but it also resulted in several unsuccessful ventures alongside a few successful ones like DraftKings and SoFi Technologies [1][2]. - Notable failures in the SPAC market include companies like Nikola, Canoo, and Lordstown Motors, which have not performed well post-merger [2]. Group 2: American Exceptionalism Acquisition Corp. A (AEXA) - Chamath Palihapitiya, known as the "SPAC King," has launched a new SPAC, American Exceptionalism Acquisition Corp. A (AEXA), which is currently trading on the NYSE and is looking to partner with companies in sectors such as AI, energy, defense, or decentralized finance [3]. - AEXA stock was launched on September 26 with an IPO of 30 million shares priced at $10 each, plus an additional 4.5 million shares from underwriters' over-allotment, valuing the company at $345 million [4]. Group 3: Palihapitiya's Approach - Palihapitiya acknowledges past challenges in the SPAC market, particularly regarding sponsor compensation and retail investor involvement, and claims that AEXA will be managed differently to improve its chances of success [5][6]. - He emphasizes that lessons learned from previous SPAC experiences will inform the management and operational strategies of AEXA [6].

NEW YORK, Oct. 01, 2025 (GLOBE NEWSWIRE) -- StoneBridge Acquisition II Corporation (Nasdaq: APACU) (the “Company”) today announced the closing of its previously announced initial public offering of 5,750,000 units (the “Offering”), which amount includes 750,000 units being issued pursuant to the over-allotment option granted by the Company to the underwriter, at an offering price of $10.00 per unit, with each unit consisting of one Class A ordinary share and one right. Each right entitles the holder to rece ...